How To Use CPT Code 90666

CPT 90666 describes the administration of an altered form of the influenza virus vaccine to provide immunity against a specific pandemic strain of influenza. This article will cover the description, procedure, qualifying circumstances, appropriate usage, documentation requirements, billing guidelines, historical information, similar codes and billing examples.

1. What is CPT Code 90666?

CPT 90666 is used to report the administration of a pandemic formulation of the influenza virus vaccine. This vaccine is specifically designed to protect against a geographically spreading form of influenza. The vaccine is injected into the muscle of the upper arm and is preservative-free.

2. Official Description

The official description of CPT code 90666 is: ‘Influenza virus vaccine (IIV), pandemic formulation, split virus, preservative free, for intramuscular use.’

3. Procedure

1. The patient is appropriately prepped for the vaccine administration.
2. The healthcare provider injects the pandemic formulation of the split virus influenza vaccine into the muscle belly of the upper arm.
3. The provider counsels the patient, providing instructions and precautions before administering the vaccine.

4. Qualifying circumstances

CPT 90666 is used when a patient receives the pandemic formulation of the influenza virus vaccine. This vaccine is specifically designed to protect against a geographically spreading strain of influenza. The vaccine is administered by a healthcare provider and is preservative-free.

5. When to use CPT code 90666

CPT code 90666 should be used when a patient receives the pandemic formulation of the influenza virus vaccine. It is important to ensure that the vaccine administered matches the specific strain of influenza that is spreading geographically. This code should not be used for other forms of the influenza vaccine or for vaccines that protect against different strains of influenza.

6. Documentation requirements

To support a claim for CPT 90666, the healthcare provider must document the following information:

• The specific pandemic formulation of the influenza virus vaccine administered
• The route of administration (intramuscular)
• Date of administration
• Any counseling provided to the patient

7. Billing guidelines

When billing for CPT 90666, ensure that the vaccine administered matches the specific pandemic formulation of the influenza virus vaccine. It is important to use the correct code to accurately reflect the vaccine administered. Additionally, follow any specific guidelines provided by payers regarding the reporting of vaccine administration codes.

8. Historical information

CPT 90666 was added to the Current Procedural Terminology system on January 1, 2011. There have been no updates or changes to the code since its addition.

9. Examples

1. A healthcare provider administers the pandemic formulation of the influenza virus vaccine to a patient to protect against a specific strain of influenza that is spreading geographically.
2. A patient receives the preservative-free influenza virus vaccine to provide immunity against a pandemic strain of influenza.
3. A healthcare provider injects the split virus influenza vaccine into the muscle of the upper arm to protect against a geographically spreading form of influenza.
4. A patient receives the pandemic formulation of the influenza virus vaccine to prevent infection with a specific strain of influenza that is spreading rapidly.
5. A healthcare provider administers the preservative-free influenza virus vaccine to a patient to provide immunity against a pandemic strain of influenza.
6. A patient receives the split virus influenza vaccine to protect against a geographically spreading form of influenza.
7. A healthcare provider injects the pandemic formulation of the influenza virus vaccine into the muscle of the upper arm to prevent infection with a specific strain of influenza that is spreading rapidly.
8. A patient receives the preservative-free influenza virus vaccine to provide immunity against a pandemic strain of influenza.
9. A healthcare provider administers the split virus influenza vaccine to a patient to protect against a geographically spreading form of influenza.
10. A patient receives the pandemic formulation of the influenza virus vaccine to prevent infection with a specific strain of influenza that is spreading rapidly.